<DOC>
	<DOC>NCT01883284</DOC>
	<brief_summary>Epigenetic modifiers has been showed to rescue F508del-CFTR channel to apical membrane of epithelial cell lines. In this study, the investigators evaluate epigenetic modifiers effects firstly on CFTR rescue, then on secretion and synthesis of inflammatory factors (IL-8, LXA4 and SCGB1A1) and mucines (MUC5AC and MUC5B) in a dynamic epithelium model using an air-liquide interface culture of nasals cells from CF patients or controls.</brief_summary>
	<brief_title>Action of Epigenetic Modifiers in Cystic Fibrosis Treatment</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>General inclusion criteria : informed consent benefit from disease insurance regimen men and women Inclusion Criteria for CF patients 2 severe CF mutations age superior or equal to 12 Inclusion Criteria for controls : age superior or equal to 18 no smoker (for 5 years) General exclusion criteria : participation to an other interventionnal study subject in exclusion period law protected subject pregnant and breast fooding Specific Xylocaine hypersensibility Porphyria severe hepatic failure Epilepsy Severe cardiac failure local anesthesic contra indication Specific Control subject respiratory disease cystic fibrosis acute infection &lt; 6 weeks on treatment antibiotic treatment &lt; 3 months</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>nasal epithelia</keyword>
	<keyword>mucins</keyword>
</DOC>